13.0837  -0.275 (-2.06%)		09-30 16:00
Open: 13.27 High: 13.424 Volume: 6,327		Pre. Close: 13.359 Low: 12.99 Market Cap: 2(M)

Short term
Mid term
Targets	6-month :	16.29	1-year :	16.99
Resists	First :	13.95	Second :	14.55
Pivot price	13.68
Supports	First :	12.98	Second :	10.8
MAs	MA(5) :	13.55	MA(20) :	13.69
	MA(100) :	16.17	MA(250) :	16.78
MACD	MACD :	-0.3	Signal :	-0.4
%K %D	K(14,3) :	14.6	D(3) :	32.9
RSI	RSI(14): 37.5
52-week	High :	25.87	Low :	12.98

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ BIS ] has closed below the lower bollinger band by 2.4%. Bollinger Bands are 46.6% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 21 bars. This is a sign that the market may be about to initiate a new trend.

If tomorrow:	Open lower	Open higher
High:	13.44 - 13.55	13.55 - 13.62
Low:	12.76 - 12.88	12.88 - 12.96
Close:	12.93 - 13.11	13.11 - 13.24

The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the fund's investment objective. The index is a modified capitalization weighted index that includes securities of Nasdaq listed companies that are classified as either biotechnology or pharmaceutical. The fund is non-diversified.

Tue, 16 Sep 2025
ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS) Sees Significant Decline in Short Interest - Defense World

Wed, 14 May 2025
Top Performing Leveraged/Inverse ETFs: 05/11/2025 - ETF Trends

Tue, 19 Nov 2024
Top Performing Leveraged/Inverse ETFs: 11/17/2024 - ETF Trends

Thu, 16 Feb 2023
ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS) Sees Significant Growth in Short Interest - 富途牛牛

Thu, 14 Jul 2022
ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS) Short Interest Up 644.1% in June - 富途牛牛

Wed, 06 Jul 2022
Short Interest in ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS) Decreases By 21.9% - 富途牛牛

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Neutral
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Neutral
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Neutral
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Neutral
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Neutral
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Neutral

Exchange: NASDAQ
Sector: Financial Services
Industry: Asset Management
Shares Out	0 (M)
Shares Float	0 (M)
Held by Insiders	0 (%)
Held by Institutions	0 (%)
Shares Short	0 (K)
Shares Short P.Month	0 (K)

EPS	0
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	0
Profit Margin	0 %
Operating Margin	0 %
Return on Assets (ttm)	0 %
Return on Equity (ttm)	0 %
Qtrly Rev. Growth	0 %
Gross Profit (p.s.)	0
Sales Per Share	0
EBITDA (p.s.)	0
Qtrly Earnings Growth	0 %
Operating Cash Flow	0 (M)
Levered Free Cash Flow	0 (M)

PE Ratio	0
PEG Ratio	0
Price to Book value	0
Price to Sales	0
Price to Cash Flow	0

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.